Trump of­fi­cials dou­ble up on Mod­er­na vac­cine sup­ply, eye­ing H1 mR­NA cam­paign as Big Phar­mas stum­ble

As most of the Big Phar­ma vac­cine play­ers fall fur­ther and fur­ther be­hind in the scram­ble to come up with a glob­al sup­ply of vac­cines to com­bat the Covid-19 vac­cine, the US gov­ern­ment has struck a deal to dou­ble the amount of vac­cine they will get from Mod­er­na next year.

HHS sec­re­tary Alex Azar, who’s been push­ing the FDA to trig­ger a snap OK for an EUA ap­proval for the Pfiz­er/BioN­Tech mR­NA vac­cine, an­nounced a deal to ac­quire an ex­tra 100 mil­lion dos­es from Mod­er­na —all set to be de­liv­ered in Q2. That comes on top of 20 mil­lion dos­es that ships this month with the rest due in Q1.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.